Chargement en cours...
Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavaila...
Enregistré dans:
| Publié dans: | Asian J Pharm Sci |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Shenyang Pharmaceutical University
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8261086/ https://ncbi.nlm.nih.gov/pubmed/34276821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2020.07.003 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|